Lilly's New Weight Loss Pill Just Launched - Here's the Deal
Foundayo is now available at pharmacies nationwide, and it's priced to compete directly with Novo's oral Wegovy at $149/month.
The New Kid on the Block: Foundayo
Eli Lilly just made good on their promise. Foundayo (orforglipron), their new oral GLP-1 pill for weight loss, hit pharmacy shelves this week after getting FDA approval on April 1st. If you've been waiting for more options beyond injections, this might be worth your attention.
The pill showed some solid results in clinical trials - people lost an average of 27.3 pounds (about 12.4% of their body weight) at the highest dose. That's pretty comparable to what we see with other GLP-1 medications, though your mileage will definitely vary.
Here's what makes Foundayo different: you can take it anytime, with or without food, and you don't need water. That's a nice change from some other oral options that come with strict timing rules.
Pricing That Actually Makes Sense
Lilly clearly did their homework on pricing. They're charging $149/month for self-pay patients - exactly what Novo charges for oral Wegovy. With commercial insurance, you might pay as little as $25/month, though that depends entirely on your specific plan.
You can get it through LillyDirect (their online service) or telehealth providers, and they'll ship it to your local pharmacy. No special handling required since it's a regular pill.
The Competition Heats Up
This launch sets up an interesting face-off with Novo Nordisk, who got their oral Wegovy to market about three months earlier. Both companies are betting that people want pills instead of weekly injections, and honestly, they're probably right.
Lilly's already had major success with their injectable Zepbound and Mounjaro, so they're not starting from scratch here. They know this market, and they know what people are looking for: convenience, results, and reasonable pricing.
The flexible dosing schedule could give Foundayo an edge. While oral Wegovy has specific timing requirements, Foundayo lets you fit it into your actual life instead of restructuring your day around a pill.
What This Means for You
More competition usually means better options for patients. Both companies will be fighting for market share, which should keep prices competitive and push them to improve their services.
If you're currently struggling with injection anxiety or just want something easier to manage, having two oral options gives you more leverage with insurance companies and more flexibility in choosing what works for your lifestyle.
Bottom Line
Foundayo gives you another solid option in the GLP-1 space, especially if you prefer pills over injections. The pricing is competitive, the dosing is flexible, and the results look promising. Just remember that like any GLP-1 medication, it's not magic - you'll still need to work on diet and lifestyle changes to see the best results. Talk to your doctor about whether it makes sense for your situation.
